Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 18,292 results that match your search.18,292 results
  • On July 24 2003 the National Copyright Administration of China (NCAC) issued the new Implementing Measures for Administrative Penalties on Copyright Infringement, effective September 1 2003, to replace the earlier measures issued in 1997. The Measures aim to make the provisions consistent with those of the new Copyright Law and Copyright Implementing Regulations which underwent substantial amendments in 2001 and 2002 respectively. Moreover, they supplement the Law and the Implementing Regulations so as to make them more operable when it comes to administrative enforcement of copyright. The major changes are as follows.
  • The advent of computers and electronic communication has added a new dimension to preserving evidence, explains Glen P Belvis of Brinks Hofer Gilson & Lione
  • Filing trade marks in Hong Kong
  • Stéphanie Bodoni, London
  • Decisive action and planning by in-house counsel can help a company facing patent infringement gain an early advantage, maintain H Dickson Burton and Krista Weber Powell of TraskBritt in the US
  • The counterfeit industry in Korea is proving hard to contain. Korean counterfeiters are producers and exporters of fake goods on a global scale. But now trade mark owners have organized themselves and are fighting back. Ralph Cunningham reports
  • Wu Yuhe and Dong Jiangxong, of China Patent Agent (HK) Ltd, explain what you should know about patent and trade mark assignment, licensing and technology transfer in China
  • In Sweden, the Läkemedelsverket (Swedish Medical Products Agency) withdrew the authorization of parallel imports of the medicinal product Losec enterokapslar (Losec enteric capsules to treat conditions caused by stomach acid) into Sweden by Paranova only because the authorization for the directly imported medicinal product by the official Swedish distributor was withdrawn. One cannot place medicinal products on the market in a member state unless a marketing authorization has been issued by the competent authority of that member state (Article 3 of Directive 65/65/EEC of the Council of January 26 1965 as amended by Council Directive 93/39/EEC of June 14 1993). Parallel importer Paranova opposed to the decision to withdraw her authorization. Did Paranova succeed?
  • Though the NBA seeks to promote its brand abroad, looking after its rights in the US is still a critical part of Kathryn Barrett Park’s job.
  • A subsidiary of San Miguel, the Philippines food, drinks and packaging company, has temporarily stopped one of its rivals producing a brand of gin which it claims infringes one of its trade marks.